Citations

Showing 10 of 108083 citations.

The CAR-Hematotox Score Identifies Patients at High Risk for Hematological Toxicity, Infections and Poor Clinical Outcomes Following Brexucabtagene Autoleucel in Relapsed/Refractory Mantle Cell Lymphoma
Albanyan, Omar , Iacoboni, Gloria , Mohty, Razan , Dreyling, Martin, Lin, Yi , Subklewe, Marion , Rejeski, Kai , Wang, Yucai , Muñoz, Javier , Sesques, Pierre , López‐Corral, Lucía , Locke, Frederick L. , Barba, Pere , Bachy, Emmanuel , Jain, Michael D.

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 651-653

10.1182/blood-2022-167329 Get It

Frontline PET-Directed Therapy with Brentuximab Vedotin Plus AVD Followed By Nivolumab Consolidation in Patients with Limited Stage Hodgkin Lymphoma
Park, Steven I., Ansell, Stephen M. , Giri, Sharmila, Svoboda, Jakub , Smith, Stephen D. , Feldman, Tatyana , Budde, Elizabeth L., Ness, Andrew J, Choi, Yunsik , Bierman, Philip J., Lee, Hun Ju , Budde, Elizabeth L.

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1751-1752

10.1182/blood-2022-159258 Get It

Comparison of Treatment-Emergent Adverse Events of Covalent BTK Inhibitors in Clinical Trials in B-Cell Malignancies: A Systematic Review and Meta-Analysis
Wang, Jacqueline F, Jiang, Yi , Qi, Xinyue , Hampel, Paul J. , Leis, José F., Thanarajasingam, Gita , Inwards, David J. , Nowakowski, Grzegorz S. , Ansell, Stephen M. , Wang, Jacqueline , Wang, Jacqueline F , Hwang, Steven R. , Zhang, Shijia , Parikh, Sameer A. , Ding, Wei , Kenderian, Saad S. , Muchtar, Eli , Muñoz, Javier , Paludo, Jonas , Habermann, Thomas M. , Witzig, Thomas E. , Kay, Neil E. , Zhou, Shouhao , Wang, Yucai

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9882-9884

10.1182/blood-2022-168152 Get It

Time-Limited Maintenance with Ibrutinib after First-Line Therapy and the Incremental Impact on Minimal Residual Disease (MRD) for Patients with Chronic Lymphocytic Leukemia (CLL)
Paulus, Aneel , LaPlant, Betsy, Alegria, Victoria R., Zimmerman, Ashley, Chapin, Dustin, Sher, Taimur , Chanan‐Khan, Asher , Paulus, Aneel , Ailawadhi, Sikander , Parrondo, Ricardo D , Roy, Vivek

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9904-9905

10.1182/blood-2022-164667 Get It

Prognosis Score for Overall Survival with CAR-T Therapy in Aggressive Lymphoma
Bansal, Radhika , Khurana, Arushi , Jankowski, Matthew, Hathcock, Matthew , Hampel, Paul J. , Ansell, Stephen M. , Johnston, Patrick B. , Lin, Yi , Bennani, N. Nora , Paludo, Jonas , Wang, Yucai , Durani, Urshila

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9504-9505

10.1182/blood-2022-167622 Get It

A Multi-Center Study: Outcomes Among Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients with CD20 Loss
Takiar, Radhika , Ng, Wern Lynn , Shah, Eshana, Boonstra, Philip S. , Karimi, Yasmin , Zamalloa, Carlos A. Murga, Nowakowski, Grzegorz S. , Karimi, Yasmin H , Carty, Shannon A. , Wilcox, Ryan A. , Phillips, Tycel

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9510-9511

10.1182/blood-2022-158825 Get It

Circulating Tumor DNA As a Biomarker for Molecular Residual Disease Assessment in Patients with Diffuse Large B-Cell Lymphoma
Narkhede, Mayur , LaBarbera, Katie , Widden, Hayley, Benrud, Ryan, Kalashnikova, Ekaterina, Malashevich, Allyson Koyen , Liu, Minetta C. , Aleshin, Alexey , Tomassetti, Sarah , Iqbal, Madiha , LaBarbera, Katie, Rathore, Richa , Kalashnikova, Ekaterina

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11884-11886

10.1182/blood-2022-169656 Get It

The Lupus Anticoagulant Titer Is Associated with Elevated Anti-Phosphatidyl-Serine/Prothrombin Antibody Levels
Pruthi, Rajiv K. , Heikal, Nahla, Snyder, Melissa R. , Ashrani, Aneel A. , Seheult, Jansen N. , Seheult, Jansen N , Saadalla, Abdulrahman , Chen, Dong

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2669-2670

10.1182/blood-2022-170992 Get It

Fixed Duration Therapy with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone for High Risk Smoldering Multiple Myeloma-Results of the Ascent Trial
Kumar, Shaji , Alsina, Melissa , LaPlant, Betsy, Badros, Ashraf , Abonour, Rafat , Asmus, Erik, Dhakal, Binod , Rosenbaum, Cara A. , Egan, Daniel , Bhutani, Manisha , Durie, Brian G.M. , Abdallah, Al-Ola , Dhakal, Binod , Jakubowiak, Andrzej

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1830-1832

10.1182/blood-2022-168930 Get It